Company Overview of Takeda Cambridge Ltd.
Takeda Cambridge Ltd. develops a pipeline of novel drug discovery projects to treat unmet medical needs. Its drug discovery pipeline focuses on novel targets to provide treatments for neurodegeneration, psychiatric, and cardiovascular/metabolic diseases; diabetes; and Alzheimer, schizophrenia, obesity, and inflammatory diseases. Takeda Cambridge Ltd. was formerly known as Paradigm Therapeutics, Ltd. and changed its name to Takeda Cambridge Ltd. in March 2007. The company was incorporated in 1998 and is based in Cambridge, United Kingdom. As of March 29, 2007, Takeda Cambridge Ltd. operates as a subsidiary of Takeda Pharmaceutical Company Limited.
418 Science Park
Cambridge, CB4 0PZ
Founded in 1998
44 12 2347 7910
44 12 2347 7911
Key Executives for Takeda Cambridge Ltd.
Similar Private Companies By Industry
|Abbey Pharma Limited||Europe|
|Absynth Biologics Limited||Europe|
|Acacia Pharma Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Takeda Cambridge Ltd., please visit www.takedacam.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.